Cytarabine, Depocyt, Vyxeos (cytarabine) is a small molecule pharmaceutical. Cytarabine was first approved as Cytarabine on 1982-01-01. It is used to treat leukemia, lymphoma, and meningeal neoplasms in the USA. It has been approved in Europe to treat myeloid leukemia acute.
|Trade Name||Vyxeos liposomal, known as Vyxeos|
|Indication||leukemia, lymphoma, meningeal neoplasms, myeloid leukemia acute|
|Drug Class||Antineoplastics (arabinofuranosyl derivatives)|